← Back to Methodology
RQS Scoring Log

MOTS-c

Longevity & Cellular Aging· Animal / In Vitro· Scored May 2026· View compound profile →
41 /100
Limited Evidence
7 dimensions · 100 points total · Methodology by PeptideClear
Dimension Breakdown
DimensionScoring NotesScore
Study Design
Mouse exercise metabolism and insulin sensitivity studies primarily. Some human correlational data on endogenous MOTS-c levels. No human intervention RCTs. Animal/in vitro.
5 / 25
Sample Size
No human intervention participants.
0 / 20
Replication
Replicated across several labs globally since initial 2015 discovery. AMPK/AICAR pathway activation findings confirmed independently. Growing preclinical base.
15 / 20
Journal Impact Factor
Original discovery published in Cell Metabolism (IF ~29). Subsequent papers in Aging Cell (IF ~8), Nature Aging. Strong journals for preclinical longevity research.
8 / 15
Funding Independence
NIH NIA and academic (USC) funded. Pinchas Cohen group — same independent researcher profile as humanin.
7 / 10
Population Diversity
Animal/in vitro. Not applicable.
3 / 5
Researcher h-Index
Pinchas Cohen (USC) h-Index 60+. Changhan Lee (USC) also strong. Top-tier longevity researchers. Capped at 5.
3 / 5
Animal Only Note
This score reflects evidence in humans. Animal and in vitro evidence may be substantially stronger than the score suggests — this compound has not yet been studied in human trials.